Total Payments
$48,069
2024 Payments
$905.71
Companies
16
Transactions
117
Medicare Patients
4,966
Medicare Billing
$437,547
Payment Breakdown by Category
Other$35,100 (73.0%)
Food & Beverage$6,747 (14.0%)
Consulting$4,800 (10.0%)
Travel$1,396 (2.9%)
Education$26.22 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $35,100 | 15 | 73.0% |
| Food and Beverage | $6,747 | 83 | 14.0% |
| Consulting Fee | $4,800 | 2 | 10.0% |
| Travel and Lodging | $1,396 | 13 | 2.9% |
| Education | $26.22 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $41,130 | 66 | $0 (2024) |
| Gilead Sciences, Inc. | $4,802 | 23 | $0 (2024) |
| GENZYME CORPORATION | $670.92 | 5 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $535.97 | 8 | $0 (2024) |
| Intuitive Surgical, Inc. | $157.58 | 1 | $0 (2017) |
| Olympus America Inc. | $156.91 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $152.21 | 2 | $0 (2019) |
| Madrigal Pharmaceuticals | $130.59 | 1 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $123.40 | 1 | $0 (2019) |
| Covidien LP | $101.70 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $905.71 | 13 | Gilead Sciences, Inc. ($244.62) |
| 2023 | $834.50 | 7 | GENZYME CORPORATION ($385.23) |
| 2022 | $403.60 | 4 | ABBVIE INC. ($183.91) |
| 2021 | $87.41 | 1 | Gilead Sciences, Inc. ($87.41) |
| 2020 | $229.80 | 2 | Olympus America Inc. ($125.00) |
| 2019 | $7,999 | 27 | AbbVie, Inc. ($7,318) |
| 2018 | $14,484 | 17 | AbbVie, Inc. ($14,412) |
| 2017 | $23,125 | 46 | AbbVie, Inc. ($18,903) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $130.59 | General |
| Category: LIVER DISEASE | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: INFLAM | ||||||
| 10/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $139.31 | General |
| Category: Immunology | ||||||
| 09/04/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $108.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/05/2024 | Olympus America Inc. | EVIS EXERA III COLONOVIDEOSCOPE (Device) | Food and Beverage | In-kind items and services | $31.91 | General |
| Category: Gastroenterology | ||||||
| 05/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: HBV | ||||||
| 12/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $139.39 | General |
| Category: Immunology | ||||||
| 08/17/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $83.13 | General |
| Category: IMMUNOLOGY | ||||||
| 06/15/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $117.09 | General |
| Category: Immunology | ||||||
| 05/05/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $118.85 | General |
| 02/28/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $122.31 | General |
| Category: HBV | ||||||
| 02/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $128.75 | General |
| Category: Immunology | ||||||
| 11/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $73.31 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/15/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $146.38 | General |
| Category: Immunology | ||||||
| 06/30/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $103.00 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2022 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $80.91 | General |
| 11/10/2021 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $87.41 | General |
| Category: HBV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,229 | 1,262 | $1.4M | $111,334 |
| 2022 | 17 | 1,232 | 1,267 | $1.3M | $106,512 |
| 2021 | 17 | 1,332 | 1,379 | $1.4M | $117,872 |
| 2020 | 16 | 1,173 | 1,227 | $1.2M | $101,828 |
Total Patients
4,966
Total Services
5,135
Medicare Billing
$437,547
Procedure Codes
65
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 193 | 193 | $441,581 | $40,408 | 9.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 201 | 202 | $377,906 | $16,728 | 4.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 116 | $39,788 | $11,414 | 28.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 156 | 156 | $217,952 | $10,900 | 5.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 39 | 39 | $63,386 | $7,048 | 11.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 60 | 60 | $31,260 | $6,275 | 20.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 19 | 19 | $30,662 | $3,599 | 11.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 45 | 49 | $11,466 | $3,320 | 29.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $32,354 | $2,810 | 8.7% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $26,357 | $2,492 | 9.5% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 13 | 13 | $16,588 | $1,877 | 11.3% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2023 | 12 | 12 | $23,028 | $1,726 | 7.5% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2023 | 338 | 346 | $85,462 | $1,462 | 1.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 12 | 12 | $9,552 | $1,004 | 10.5% |
| 74328 | Review by radiologist of image from tube placement into bile duct using an endoscope | Facility | 2023 | 13 | 14 | $2,548 | $270.76 | 10.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 156 | 159 | $351,480 | $30,824 | 8.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 212 | 214 | $395,568 | $17,563 | 4.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 180 | 183 | $249,429 | $12,250 | 4.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 88 | 99 | $32,967 | $9,265 | 28.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $33,396 | $8,606 | 25.8% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 28 | 28 | $43,625 | $5,239 | 12.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 56 | $12,712 | $3,662 | 28.8% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $31,808 | $3,120 | 9.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 19 | $8,512 | $2,504 | 29.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 15 | $9,750 | $2,444 | 25.1% |
About Dr. Abdul Khaleq, MD
Dr. Abdul Khaleq, MD is a Gastroenterology healthcare provider based in Sacramento, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558457960.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdul Khaleq, MD has received a total of $48,069 in payments from pharmaceutical and medical device companies, with $905.71 received in 2024. These payments were reported across 117 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($35,100).
As a Medicare-enrolled provider, Khaleq has provided services to 4,966 Medicare beneficiaries, totaling 5,135 services with total Medicare billing of $437,547. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Sacramento, CA
- Active Since 10/04/2006
- Last Updated 05/08/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1558457960
Products in Payments
- Mavyret (Drug) $16,536
- Humira (Biological) $14,172
- Viekira (Drug) $4,554
- Epclusa (Drug) $3,863
- DUPIXENT (Biological) $684.08
- Vemlidy (Drug) $427.92
- ENTYVIO (Biological) $351.06
- Entyvio (Biological) $189.26
- RINVOQ (Biological) $186.13
- Da Vinci Surgical System (Device) $157.58
- TRULANCE (Drug) $137.42
- RESMETIROM (Drug) $130.59
- Olympus Duodenoscopes (Device) $125.00
- STELARA (Biological) $123.40
- Livdelzi (Drug) $122.31
- SKYRIZI (Biological) $122.31
- LINZESS (Drug) $108.20
- Smart Pill (Device) $101.70
- Creon (Drug) $100.32
- EVIS EXERA III COLONOVIDEOSCOPE (Device) $31.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Sacramento
Dr. Joseph Leung, M.d, M.D
Gastroenterology — Payments: $382,939
Gastroenterology $382,939
Christopher Bowlus, M.d, M.D
Gastroenterology — Payments: $174,596
Gastroenterology $174,596
Dr. Antonio Mendoza Ladd, M.d, M.D
Gastroenterology — Payments: $84,349
Gastroenterology $84,349
Dr. Kuldeep Tagore, M.d, M.D
Gastroenterology — Payments: $53,535
Gastroenterology $53,535
Dr. Valentina Medici, M.d, M.D
Gastroenterology — Payments: $30,237
Gastroenterology $30,237
Juan Garcia, M.d, M.D
Gastroenterology — Payments: $29,516
Gastroenterology $29,516